166.45
price down icon0.28%   -0.46
after-market 시간 외 거래: 170.07 3.62 +2.17%
loading
전일 마감가:
$166.91
열려 있는:
$167.01
하루 거래량:
2.00M
Relative Volume:
1.80
시가총액:
$18.58B
수익:
$9.54B
순이익/손실:
$841.00M
주가수익비율:
22.37
EPS:
7.44
순현금흐름:
$1.02B
1주 성능:
-1.14%
1개월 성능:
-7.23%
6개월 성능:
+9.04%
1년 성능:
+14.00%
1일 변동 폭
Value
$165.30
$167.42
1주일 범위
Value
$164.65
$170.29
52주 변동 폭
Value
$137.71
$182.38

퀘스트 다이아그노스틱스 Stock (DGX) Company Profile

Name
명칭
Quest Diagnostics Inc
Name
전화
(973) 520-2700
Name
주소
500 PLAZA DRIVE, SECAUCUS
Name
직원
56,000
Name
트위터
@QuestDX
Name
다음 수익 날짜
2025-07-22
Name
최신 SEC 제출 서류
Name
DGX's Discussions on Twitter

DGX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
DGX
Quest Diagnostics Inc
166.45 18.80B 9.54B 841.00M 1.02B 7.44
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
404.94 160.56B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
188.07 141.52B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
520.87 42.74B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
112.04 34.11B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
158.96 27.70B 15.50B 1.33B 2.16B 7.34

퀘스트 다이아그노스틱스 Stock (DGX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-02 개시 Redburn Atlantic Buy
2025-03-04 다운그레이드 Citigroup Buy → Neutral
2025-01-06 업그레이드 Leerink Partners Market Perform → Outperform
2024-12-17 업그레이드 Morgan Stanley Equal-Weight → Overweight
2024-12-10 재개 Jefferies Buy
2024-10-23 업그레이드 Robert W. Baird Neutral → Outperform
2024-08-28 재개 Evercore ISI In-line
2024-07-10 업그레이드 Citigroup Neutral → Buy
2024-02-26 개시 Leerink Partners Market Perform
2024-02-07 업그레이드 Jefferies Hold → Buy
2024-01-03 개시 Barclays Equal Weight
2023-12-12 업그레이드 BofA Securities Neutral → Buy
2023-06-29 개시 Piper Sandler Neutral
2023-05-02 다운그레이드 BofA Securities Buy → Neutral
2023-04-03 업그레이드 Citigroup Sell → Neutral
2023-01-23 개시 Evercore ISI In-line
2022-11-17 다운그레이드 Citigroup Neutral → Sell
2022-08-22 재개 Morgan Stanley Equal-Weight
2022-04-04 다운그레이드 Citigroup Buy → Neutral
2022-02-23 다운그레이드 UBS Buy → Neutral
2022-02-02 다운그레이드 Jefferies Buy → Hold
2022-01-28 다운그레이드 Deutsche Bank Buy → Hold
2021-05-04 업그레이드 UBS Neutral → Buy
2021-03-12 다운그레이드 Robert W. Baird Outperform → Neutral
2020-10-21 업그레이드 Argus Hold → Buy
2020-07-29 업그레이드 KeyBanc Capital Markets Sector Weight → Overweight
2020-07-14 업그레이드 BofA Securities Neutral → Buy
2020-06-09 업그레이드 Wells Fargo Underweight → Equal Weight
2020-06-02 업그레이드 Deutsche Bank Hold → Buy
2020-04-28 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-04-27 업그레이드 Citigroup Neutral → Buy
2020-04-27 업그레이드 Wolfe Research Underperform → Peer Perform
2020-03-27 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-01-08 개시 Wells Fargo Underweight
2020-01-07 다운그레이드 Barclays Overweight → Equal Weight
2019-12-19 업그레이드 BofA/Merrill Underperform → Neutral
2019-07-15 다운그레이드 Goldman Neutral → Sell
2019-04-02 업그레이드 Jefferies Hold → Buy
2019-03-18 재개 Credit Suisse Neutral
2019-01-31 다운그레이드 Argus Buy → Hold
2019-01-17 개시 UBS Neutral
2019-01-03 다운그레이드 BofA/Merrill Neutral → Underperform
2018-12-03 다운그레이드 BofA/Merrill Buy → Neutral
2018-11-30 다운그레이드 Goldman Buy → Neutral
모두보기

퀘스트 다이아그노스틱스 주식(DGX)의 최신 뉴스

pulisher
12:37 PM

Quest Diagnostics Earnings Preview: EPS Estimate $2.57, Neutral Consensus Rating, and 12.46% Upside Potential. - AInvest

12:37 PM
pulisher
08:38 AM

Should You Buy Quest Diagnostics Ahead of Earnings? - Yahoo Finance

08:38 AM
pulisher
08:05 AM

DGX Q2 Earnings Preview: Will Advanced Diagnostics Lead Performance? - Yahoo Finance

08:05 AM
pulisher
Jul 19, 2025

Quest Diagnostics Incorporated Stock Analysis and ForecastRecord-setting profit potential - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What analysts say about Quest Diagnostics Incorporated stockTriple-digit return opportunities - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Quest Diagnostics (DGX) Maintains Neutral Rating Amid Slight PT Adjustment | DGX Stock News - GuruFocus

Jul 18, 2025
pulisher
Jul 18, 2025

Quest Diagnostics: UBS Keeps Neutral Rating, Lowers PT to $175 from $176 - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Quest Diagnostics (DGX) Faces Slight Price Target Adjustment by UBS | DGX Stock News - GuruFocus

Jul 18, 2025
pulisher
Jul 18, 2025

What drives Quest Diagnostics Incorporated stock priceHigh-octane investment gains - Jammu Links News

Jul 18, 2025
pulisher
Jul 17, 2025

11th Circ. Says Ex-Quest Diagnostics Worker's FCA Suit Fails - Law360

Jul 17, 2025
pulisher
Jul 17, 2025

Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Jul 17, 2025
pulisher
Jul 16, 2025

Quest Lab Worker Fails to Revive Billing Fraud Suit on Appeal - Bloomberg Law News

Jul 16, 2025
pulisher
Jul 15, 2025

Quest to offer Fujirebio’s FDA-cleared Alzheimer’s blood test - MedTech Dive

Jul 15, 2025
pulisher
Jul 15, 2025

Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Quest Diagnostics launches test for Oropouche virus amid spread in Americas - Investing.com Canada

Jul 15, 2025
pulisher
Jul 15, 2025

Quest Diagnostics (DGX) Launches Oropouche Virus Test | DGX Stoc - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Quest Diagnostics Introduces Testing for Oropouche Virus - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

First-Ever Commercial Test for Dangerous Oropouche Virus Launches as Disease Spreads in Americas - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

Quest Diagnostics: Buy Into Future Patient Demand, Undervalued Price Today (DGX) - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Quest Diagnostics launches test for Oropouche virus detection in United States; company's California lab will perform PCR testing for emerging disease starting late July 2025 - Industry Intelligence Inc.

Jul 15, 2025
pulisher
Jul 14, 2025

Despite Slump, Options Traders May Be Seeing Something With Quest Diagnostics (DGX) - Barchart.com

Jul 14, 2025
pulisher
Jul 14, 2025

Quest Diagnostics (DGX) Develops MCaST Blood Test with MD Anderson Cancer Center - Yahoo Finance

Jul 14, 2025
pulisher
Jul 11, 2025

Quest Diagnostics Stock Drops 2.51% Amid Analyst Upgrade - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Quest Diagnostics Surges to 417th in Trading Volume with 2.25 Billion Shares Traded - AInvest

Jul 11, 2025
pulisher
Jul 09, 2025

Quest Diagnostics (DGX) Launches FDA-Approved Alzheimer's Test - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Quest Diagnostics to offer Fujirebio Alzheimer's diagnostic test - Seeking Alpha

Jul 09, 2025
pulisher
Jul 09, 2025

Quest Diagnostics Launches Revolutionary FDA-Cleared Blood Test to Detect Early Alzheimer's with 97% Accuracy - Stock Titan

Jul 09, 2025
pulisher
Jul 08, 2025

Leerink Partners Adjusts PT on Quest Diagnostics to $192 From $189, Maintains Outperform Rating - MarketScreener

Jul 08, 2025
pulisher
Jul 07, 2025

Quest Diagnostics Stock Climbs 27.3% in a Year: What's Fueling It? - Nasdaq

Jul 07, 2025
pulisher
Jul 03, 2025

Ex-Dividend Reminder: Edison International, Quest Diagnostics and Cousins Properties - Nasdaq

Jul 03, 2025
pulisher
Jul 03, 2025

Zacks Industry Outlook Highlights Quest Diagnostics, Encompass Health, DaVita and The Pennant - TradingView

Jul 03, 2025
pulisher
Jul 02, 2025

Quest Diagnostics tops NJ life sciences employer list - NJBIZ

Jul 02, 2025
pulisher
Jul 02, 2025

Is Quest Diagnostics Stock a Smart Pick for Your Portfolio Now? - Nasdaq

Jul 02, 2025
pulisher
Jul 01, 2025

What to Expect From Quest Diagnostics' Q2 2025 Earnings Report - inkl

Jul 01, 2025
pulisher
Jul 01, 2025

What To Expect From Quest Diagnostics' Q2 2025 Earnings Report - Barchart.com

Jul 01, 2025
pulisher
Jun 27, 2025

Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Jun 27, 2025
pulisher
Jun 26, 2025

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - Yahoo Finance

Jun 26, 2025
pulisher
Jun 25, 2025

DGX Stock Up on New Blood Test Development Deal With MD Anderson - MSN

Jun 25, 2025
pulisher
Jun 25, 2025

Quest Diagnostics Transforms Healthcare Access: $13M in Grants, 1M Free Tests, and 50 New Diagnostic Services - Stock Titan

Jun 25, 2025
pulisher
Jun 23, 2025

Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025 – Company Announcement - Financial Times

Jun 23, 2025
pulisher
Jun 23, 2025

Is Quest Diagnostics Stock Outperforming the Nasdaq? - MSN

Jun 23, 2025
pulisher
Jun 23, 2025

Is Quest Diagnostics Stock Outperforming The Nasdaq? - Barchart.com

Jun 23, 2025
pulisher
Jun 16, 2025

Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years - Benzinga

Jun 16, 2025
pulisher
Jun 13, 2025

Quest Diagnostics stock hits all-time high of $180.11 By Investing.com - Investing.com Canada

Jun 13, 2025
pulisher
Jun 13, 2025

Quest partners with MD Anderson to develop cancer risk blood test - MedTech Dive

Jun 13, 2025
pulisher
Jun 11, 2025

Quest Diagnostics and University of Texas want to promote more cancer screenings - Mugglehead Magazine

Jun 11, 2025
pulisher
Jun 11, 2025

Fecal Immunochemical Diagnostic Test (FIT) Market Top - openPR.com

Jun 11, 2025
pulisher
Jun 10, 2025

Quest Diagnostics (DGX) Collaborates with MD Anderson for Cancer Risk Test Development | DGX Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Quest Diagnostics New Blood Test Could Transform Early Cancer Detection for 9 Major Cancers - Stock Titan

Jun 10, 2025
pulisher
Jun 10, 2025

Quest Diagnostics Incorporated : The stock forcefully approaches new pivot levels - MarketScreener

Jun 10, 2025
pulisher
Jun 09, 2025

Quest Diagnostics (DGX) Stock Analysis: Navigating a 5.5% Upside with Strong Revenue Growth - DirectorsTalk Interviews

Jun 09, 2025

퀘스트 다이아그노스틱스 (DGX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$140.63
price up icon 1.25%
diagnostics_research LH
$243.04
price down icon 0.28%
diagnostics_research WAT
$281.66
price down icon 2.04%
diagnostics_research MTD
$1,166.48
price down icon 2.37%
diagnostics_research IQV
$158.96
price down icon 1.04%
자본화:     |  볼륨(24시간):